The clinical pharmacology of etoposide: an update.
Joel
S
S
ICRF Department of Medical Oncology, St Bartholomew's Hospital, London, U.K.
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D004357:Drug Synergism; D005047:Etoposide / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000139:chemically induced
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide